9 Mar 2021 07:00
9 March 2021
Â
Hemogenyx Pharmaceuticals plcÂ
("Hemogenyx Pharmaceuticals" or the "Company")
Â
Director/PDMR Shareholding
Â
Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that it has been notified that Andrew Wright, the Company's Financial Controller and Company Secretary (PDMR), has purchased 94,882 ordinary shares of £0.01 each in the Company ("Ordinary Shares") at an average price of 6.03p per share. Following this transaction, Mr Wright has a total beneficial interest in 1,626,991 Ordinary Shares, representing approximately 0.36 per cent of the Company's issued share capital.
Â
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
Â
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Â
Â
1. | Details of PDMR/person closely associated with them ("PCA") | |||||
a) | Name | Andrew Wright | ||||
b) | Position/status | PDMR: Financial Controller and Company Secretary | ||||
c) | Initial notification/amendment | Initial notification | ||||
2. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of Hemogenyx Pharmaceuticals plcIdentification code GB00BYX3WZ24 | ||||
b) | Nature of the transaction | Standalone acquisition of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
| ||||
e) | Date of the transaction | 2021-03-08 | ||||
f) | Place of the transaction | London Stock ExchangeXLON |
Â
Â
Enquiries:
Â
Hemogenyx Pharmaceuticals plc | https://hemogenyx.com |
Dr Vladislav Sandler, Chief Executive Officer & Co-Founder | headquarters@hemogenyx.com |
Peter Redmond, Director | peter.redmond@hemogenyx.com |
SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 |
Matthew Johnson, Vadim Alexandre, Adam Cowl | |
Peterhouse Capital Limited | Tel: +44 (0)20 7469 0930 |
Lucy Williams, Duncan Vasey, Charles Goodfellow | |
Â